2 No-Brainer Dividend Stocks to Buy in 2026
Source: Motley Fool
2026-03-08 12:47:00 ET
Dividend stocks are not all the same. Some will readily decrease or suspend their payouts at the first sign of trouble, while others will continue increasing them even during market downturns or economic recessions.
Dividend investors prefer those that are in the latter category. Let's consider two stocks along those lines that are worth buying: Johnson & Johnson (NYSE: JNJ) and Zoetis (NYSE: ZTS) . These two healthcare companies are excellent picks for income-oriented investors.
Image source: Getty Images.
Zoetis Inc. Class A
NASDAQ: ZTS
ZTS Trading
2.35% G/L:
$122.39 Last:
961,212 Volume:
$121.95 Open:
ZTS Latest News
March 02, 2026 07:00:00 am
Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation
ZTS Stock Data
$56,889,086,995
440,384,729
0.02%
903
N/A
Pharmaceuticals
Healthcare
US
Parsippany
